Page last updated: 2024-08-25

oxazolidin-2-one and Infection, Mycobacterium avium-intracellulare

oxazolidin-2-one has been researched along with Infection, Mycobacterium avium-intracellulare in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Jhun, BW; Kim, LH; Kim, SY; Lee, JM; Lee, W; Shin, SJ1
Bertó, J; Del Pozo, JL; Leiva, J; Yuste, JR1
Carson, J; Cerda, J; Chae, JH; Hirano, M; Maggiore, P1
Falagas, ME; Ntziora, F1
Binstock, P; Keating, M; Kontoyiannis, DP; Nannini, EC; Samonis, G1

Reviews

1 review(s) available for oxazolidin-2-one and Infection, Mycobacterium avium-intracellulare

ArticleYear
Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2007, Volume: 11, Issue:6

    Topics: Acetamides; Adolescent; Adult; Anemia; Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Optic Nerve Diseases; Oxazolidinones; Peripheral Nervous System Diseases; Treatment Outcome; Tuberculosis

2007

Other Studies

4 other study(ies) available for oxazolidin-2-one and Infection, Mycobacterium avium-intracellulare

ArticleYear
Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection.
    Scientific reports, 2023, Nov-23, Volume: 13, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Humans; Lung Diseases; Macrolides; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones

2023
Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.
    The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Drug Tolerance; Humans; Linezolid; Lung; Male; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nontuberculous Mycobacteria; Oxazolidinones; Tetrazoles; Time Factors

2017
Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism.
    Pharmacotherapy, 2007, Volume: 27, Issue:5

    Topics: Acetamides; Acidosis, Lactic; Adult; Anti-Infective Agents; DNA, Mitochondrial; Female; Genetic Predisposition to Disease; Humans; Linezolid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones; Polymorphism, Genetic

2007
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.
    The Journal of infection, 2002, Volume: 44, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linezolid; Male; Mefloquine; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones; Quinolines

2002